Similar articles

• Assessment of targeted automated messages on herpes zoster immunization numbers in an independent community pharmacy.

  Bedwick BW, Garofoli GK, Elswick BM. Bedwick BW, et al. J Am Pharm Assoc (2003). 2017 May-Jun;57(3S):S293-S297.e1. doi: 10.1016/j.japh.2017.02.007. Epub 2017 Apr 10. J Am Pharm Assoc (2003). 2017. PMID: 28408168
• Adult vaccination as the cornerstone of successful ageing: the case of herpes zoster vaccination. A European Interdisciplinary Council on Ageing (EICA) expert focus group.

  Ecarnot F, Bernabei R, Gabutti G, Giuffrida S, Michel JP, Rezza G, Maggi S. Ecarnot F, et al. Aging Clin Exp Res. 2019 Mar;31(3):301-307. doi: 10.1007/s40520-019-01154-1. Epub 2019 Feb 25. Aging Clin Exp Res. 2019. PMID: 30805865 Review.
• Safety of herpes zoster vaccination among inflammatory bowel disease patients being treated with anti-TNF medications.

  Khan N, Shah Y, Trivedi C, Lewis JD. Khan N, et al. Aliment Pharmacol Ther. 2017 Oct;46(7):668-672. doi: 10.1111/apt.14257. Epub 2017 Aug 14. Aliment Pharmacol Ther. 2017. PMID: 28805309
• Cost-effectiveness of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.

  Hornberger J, Robertus K. Hornberger J, et al. Ann Intern Med. 2006 Sep 5;145(5):317-25. doi: 10.7326/0003-4819-145-5-200609050-00004. Ann Intern Med. 2006. PMID: 16954357
• Immune senescence and vaccines to prevent herpes zoster in older persons.

  Levin MJ. Levin MJ. Curr Opin Immunol. 2012 Aug;24(4):494-500. doi: 10.1016/j.coi.2012.06.002. Epub 2012 Aug 2. Curr Opin Immunol. 2012. PMID: 22857823 Review.